My research interests focus on developing novel and innovative vaccine technologies against emerging and re-emerging viruses to prevent widespread disease and loss of life, assessing immune responses to viral infections, and vaccination with a focus on T and B lymphocytes as well as natural killer cells (NK). Furthermore, flavivirus pathogenesis, the development of novel multifunctional immunological assays. I am also interested in the generation and characterization of therapeutics recombinant human monoclonal antibodies and studying the infectious epidemiology of emerging and re-emerging RNA viruses.